DeepMed Research

Myriad Genetic Laboratories, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

Active, not recruiting

Conditions: Prostate Cancer

First Posted Date: 2020-05-28

Last Posted Date: 2025-01-15

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 500

Registration Number: NCT04404894

Locations: 🇺🇸
Urology Centers of Alabama, Homewood, Alabama, United States
🇺🇸
VA Long Beach Healthcare System, Long Beach, California, United States
🇺🇸
Manatee Medical Research Institute, Bradenton, Florida, United States

and more 4 locations

EndoPredict® Extended Endocrine Trial (EXET)

Terminated

Conditions: Primary Invasive Breast Cancer

Interventions: Other: Observational

First Posted Date: 2019-07-12

Last Posted Date: 2022-05-17

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 855

Registration Number: NCT04016935

Locations: 🇺🇸
UPMC Memorial, York, Pennsylvania, United States
🇺🇸
AON Hematology Oncology Clinic, Baton Rouge, Louisiana, United States
🇺🇸
Allegheny Health Network, Pittsburgh, Pennsylvania, United States

and more 43 locations

A Registry for Hereditary Cancer Risk Assessment and Genetic Testing

Completed

Conditions: Prostate Cancer

First Posted Date: 2019-07-10

Last Posted Date: 2020-11-05

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 255

Registration Number: NCT04015102

Locations: 🇺🇸
Associated Medical Professionals of New York, Syracuse, New York, United States
🇺🇸
Associated Urologists of North Carolina, Raleigh, North Carolina, United States
🇺🇸
Urologic Specialists of Northwest Indiana, Merrillville, Indiana, United States

and more 6 locations

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

Completed

Conditions: Prostate Cancer

First Posted Date: 2018-04-27

Last Posted Date: 2020-10-06

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 774

Registration Number: NCT03511235

Locations: 🇺🇸
Kar Urology, Orange, California, United States
🇺🇸
Golden Gate Urology, San Francisco, California, United States
🇺🇸
University of Michigan Urology Cancer Center, Ann Arbor, Michigan, United States

and more 5 locations

Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer

Terminated

Conditions: Prostate Cancer

Interventions: Diagnostic Test: Prolaris Testing

First Posted Date: 2017-09-25

Last Posted Date: 2022-06-23

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 524

Registration Number: NCT03290508

Locations: 🇺🇸
Urology Group of Florida, Delray Beach, Florida, United States
🇺🇸
A.M.P. Radiation Oncology, Syracuse, New York, United States
🇺🇸
Lehigh Valley Health Network, Allentown, Pennsylvania, United States

and more 31 locations

Endometriosis Biomarker Discovery Study

Withdrawn

Conditions: Endometriosis
Chronic Pelvic Pain

First Posted Date: 2017-09-05

Last Posted Date: 2017-09-05

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Registration Number: NCT03272360

Prospective Prolaris Value and Efficacy

Terminated

Conditions: Prostate Cancer

Interventions: Behavioral: Prolaris

First Posted Date: 2017-05-15

Last Posted Date: 2022-06-13

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 1511

Registration Number: NCT03152448

Locations: 🇺🇸
VA San Diego Healthcare System, San Diego, California, United States
🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
🇺🇸
Kansas City VAMC, Kansas City, Kansas, United States

and more 9 locations

Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

Completed

Conditions: Hereditary Cancer

Interventions: Diagnostic Test: Diagnostic Test

First Posted Date: 2017-03-16

Last Posted Date: 2017-08-08

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 145

Registration Number: NCT03081455

Locations: 🇺🇸
Westwood Women's Health, Waterbury, Connecticut, United States
🇺🇸
Associates for Women's Medicine, Syracuse, New York, United States

Combined Breast Cancer Risk Study

Completed

Conditions: Hereditary Cancer

Interventions: Diagnostic Test: Diagnostic test

First Posted Date: 2017-03-01

Last Posted Date: 2019-01-15

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 553

Registration Number: NCT03067389

Locations: 🇺🇸
The Breast Center of Northwest Arkansas, Fayetteville, Arkansas, United States
🇺🇸
Cuda Women's Health Center, Hyannis, Massachusetts, United States
🇺🇸
Elizabeth Wende Breast Care, Rochester, New York, United States

and more 1 locations

Bipolar Proteomic Assay Validation Study

Completed

Conditions: Major Depressive Disorder, Bipolar I and Bipolar II

Interventions: Other: Diagnostic test (LDT)

First Posted Date: 2016-04-21

Last Posted Date: 2020-05-14

Lead Sponsor: Myriad Genetic Laboratories, Inc.

Target Recruit Count: 261

Registration Number: NCT02746367

Locations: 🇺🇸
Lindner Center of HOPE/University of Cincinnati College of Medicine, Mason, Ohio, United States
🇺🇸
University of Iowa Health Care, Department of Psychiatry, Iowa City, Iowa, United States
🇺🇸
University of Pittsburgh Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy